Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) FCF Margin (2016 - 2025)

Fortress Biotech (FBIO) has 12 years of FCF Margin data on record, last reported at 35.89% in Q3 2025.

  • For Q3 2025, FCF Margin rose 9169.0% year-over-year to 35.89%; the TTM value through Sep 2025 reached 1188.93%, up 261208.0%, while the annual FY2024 figure was 5346.07%, 289267.0% down from the prior year.
  • FCF Margin reached 35.89% in Q3 2025 per FBIO's latest filing, up from 167.92% in the prior quarter.
  • Across five years, FCF Margin topped out at 87.7% in Q4 2023 and bottomed at 7457.89% in Q2 2022.
  • Average FCF Margin over 5 years is 543.8%, with a median of 191.13% recorded in 2021.
  • Peak YoY movement for FCF Margin: crashed -726565bps in 2022, then skyrocketed 726631bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 222.44% in 2021, then crashed by -31bps to 292.22% in 2022, then soared by 130bps to 87.7% in 2023, then plummeted by -64bps to 31.47% in 2024, then tumbled by -214bps to 35.89% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 35.89% in Q3 2025, 167.92% in Q2 2025, and 148.89% in Q1 2025.